Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists move closer to developing a new class of asthma and allergy drugs

15.02.2008
A team of Biotechnology and Biological Sciences Research Council (BBSRC) funded scientists has moved a step closer to developing a new class of effective asthma and allergy drugs.

With new research published today (15 February) in The Journal of Immunology, the team from Barts and The London School of Medicine and Dentistry has found an important target that holds significant promise for millions of people suffering from allergies, asthma, rheumatoid arthritis and a range of other inflammatory diseases. This work confirms that a key component of the body's own response to allergy-causing agents (allergens) can be targeted to reduce allergic reactions in mice.

At present, the majority of treatments for asthma and allergies focus on reducing symptoms such as an inflamed airway or runny nose and itchy eyes. Because allergies are essentially an over-the-top immune response to allergens (such as dust, peanuts, or insect bites), it is possible to give a treatment that dampens down the immune system. However this is very risky, leaving the person vulnerable to infection, and so is only used in the most extreme cases - for most people treatments that manage the symptoms of allergy are the best option. The BBSRC team led by Professor Bart Vanhaesebroeck has shown that by targeting a molecule called p110delta it is possible to interfere in the allergic reaction before symptoms occur, but without shutting down the immune system.

p110delta is a member of a family of eight proteins called PI3Ks, which control important biological functions. Their activity is implicated in many different diseases including cancer and they are an important target for drugs. However, drugs that act on all PI3K family members tend to be toxic in the body. For this reason Professor Vanhaesebroeck's team uses genetic techniques to find out which PI3K family members are linked to specific diseases. By gaining a better understanding of each PI3K they hope to target drugs more specifically and reduce the potential for side effects.

... more about:
»Allergic »Allergy »Asthma »PI3K »p110delta »reaction »symptoms

The p110gamma member of the PI3K family had previously been implicated in allergic reactions and was thought to be more important than p110delta. However, in the current study, Prof Vanhaesebroeck's team has confirmed that p110delta, but not p110gamma, is important for allergic reactions in a mouse model. These results will help to inform and drive decisions in industry to prioritise which PI3K family members should be targeted for further investment and development. The next step to develop p110delta blockers is now ongoing in industry, and is expected to proceed into the preclinical arena in humans in the near future.

Lead author of the study, Dr Khaled Ali said: "p110delta was first identified in 1997 and, and although we had our suspicions, at that time we had no idea how important it would turn out to be. This work shows that we have the potential to take control of the body's reaction to an allergen and prevent symptoms from occurring."

Professor Vanhaesebroeck added: "This work confirms our previous findings and shows once and for all that in an allergic reaction it is p110delta that is the key player among the PI3K molecules. We are very hopeful that a drug for human patients can be developed in the very near future. This approach offers the potential for therapies for asthma and allergies that target the real causes, not just symptoms."

Professor Nigel Brown, BBSRC Director of Science and Technology, said: "Allergies alone cause misery for millions every year and is of significant cost the UK due to lost productivity. This research, basic bioscience funded by BBSRC, together with industry collaboration could mean an entirely new way of dealing with asthma and allergies."

Press Office | alfa
Further information:
http://www.bbsrc.ac.uk
http://www.bbsrc.ac.uk/media

Further reports about: Allergic Allergy Asthma PI3K p110delta reaction symptoms

More articles from Life Sciences:

nachricht A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich

nachricht New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>